Revolutionizing Fibroid Care: UnitedHealthcare Embraces Gynesonics' Incision-Free Sonata Procedure
Gynesonics, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is pleased to announce that its Sonata Procedure is now covered by UnitedHealthcare.
UnitedHealthcare offers the full spectrum of health benefit programs for individuals, employers, and Medicare and Medicaid beneficiaries, and contracts directly with more than 1.5 million physicians and care professionals, and 7,000 hospitals and other care facilities nationwide.
The Sonata System is a technology platform that integrates the first and only commercial intrauterine ultrasound system with a proprietary advanced radiofrequency ablation device, providing an incision-free, uterus-preserving, transcervical treatment for symptomatic uterine fibroids. The corresponding Sonata Procedure is a breakthrough alternative to hysterectomy and myomectomy, and can treat a wide range of fibroid types, sizes, and locations. Fibroids are treated from inside the uterus, so the Sonata Procedure requires no incisions, no tissue is surgically removed, and the uterus is preserved.
Commenting on the coverage, Skip Baldino, President and Chief Executive Officer of Gynesonics said, “This positive coverage decision by UnitedHealthcare underscores the significant safety, efficacy and economic benefits that our Sonata technology provides to patients, providers and payers. With all top five payers covering Sonata, we are excited to provide access to millions of women suffering from symptomatic fibroids and seeking a less invasive treatment option.”
Jenny Zimmer, Manager of Reimbursement and Payor Relations for Gynesonics added, “We are extremely pleased to see UnitedHealthcare recognize the need for less invasive procedures like Sonata to treat uterine fibroids. Their decision to cover Sonata marks a significant victory for women across the country!”
Published on : 02nd August, 2023